B. Vasseur

1.3k citations

34 papers · 887 indexed · h-index 12

Impact in

Oncology top 5%
- Viral-associated cancers and disorders
- HER2/EGFR in Cancer Research
- Polyomavirus and related diseases
- Cancer Treatment and Pharmacology
Pathology and Forensic Medicine top 10%
- Lymphoma Diagnosis and Treatment

Papers in

Otorhinolaryngology 3
- Head and Neck Cancer Studies 3
Oncology 18
- Cancer Immunotherapy and Biomarkers 7
- Lung Cancer Research Studies 3

Co-authors: A.-M. Stoppa Pierre Quartier Bruno Hurault de Ligny Yves Réguerre J. L. Garnier C. Antoine A. Mathieu-Boué V. Leblond
Journals: Journal of Clinical Oncology (6 papers)Annals of Oncology (5 papers)Cancer (2 papers)Journal of Hepatology (2 papers)CHEST Journal (2 papers)
Partner nations: France United States Spain

In The Last Decade

B. Vasseur

30 papers receiving 857 citations

Peers

Countries citing papers authored by B. Vasseur

Since Specialization

Citations

This map shows the geographic impact of B. Vasseur's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B. Vasseur with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B. Vasseur more than expected).

Fields of papers citing papers by B. Vasseur

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by B. Vasseur. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B. Vasseur. The network helps show where B. Vasseur may publish in the future.

Co-authorship network

The 25 scholars most cited alongside B. Vasseur, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with B. Vasseur Line = papers co-authored together B. Vasseur links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Phase 3 trial of the therapeutic cancer vaccine OSE2101 versus docetaxel in patients with metastatic non-small cell lung cancer and secondary resistance to immunotherapy. Journal of Clinical Oncology ·Stephen V. Liu, José A. Lucas Cardoso, Elvire Pons‐Tostivint, Raffaele Califano, Ludovic Doucet, Thomas Egenod, Rafał Dziadziuszko, Santiago Viteri, Federico Cappuzzo, Silvia Comis, Luis Flores, Guli AXMATOVA, Michelle Suparman, François Montestruc, B. Vasseur, J. Remon Masip, Benjamin Besse	2025	1
2	1397TiP Phase III trial of the therapeutic cancer vaccine OSE2101 versus docetaxel in patients with metastatic non-small cell lung cancer and secondary resistance to immunotherapy Annals of Oncology ·Giulia Papiani, Ryan Jepson, Santiago Viteri, I Lilie-Szyszkowicz, Silvia Comis, Guli AXMATOVA, Clément Chevalier, Michelle Suparman, Aulia Rahmah, B. Vasseur, J.E. Francfort, K Adams	2024	1
3	Abstract 2129: Predictive response biomarkers from Phase I clinical trial of a SIRPalpha inhibitor BI765063, stand-alone and in combination with ezabenlimab, a PD1 inhibitor, in patients with advanced solid tumors Cancer Research ·Stéphane Champiat, Philippe A. Cassier, Nuria Kotecki, Carlos Gomez-Roca, 夏天喜, Jack Sohmer, Antoîne Italiano, Mabrouk Elgadi, Michelle Suparman, Isabelle Girault, Nina Salabert, Gisela Friebel, Nicolas Poirier, B. Vasseur, Friedrich von Sallet, Mhm van der Linden, Françoise Bono, Jean‐Pierre Delord	2023	2
4	Safety, pharmacokinetics, efficacy, and preliminary biomarker data of first-in-class BI 765063, a selective SIRPα inhibitor: Results of monotherapy dose escalation in phase 1 study in patients with advanced solid tumors. Journal of Clinical Oncology ·Stéphane Champiat, Philippe A. Cassier, Nuria Kotecki, 夏天喜, Armelle Vinceneux, Christiane Jungels, Jon Blatchford, Mabrouk Elgadi, Nicole Clarke, Mhm van der Linden, Nicolas Poirier, B. Vasseur, Aurélien Marabelle, Jean‐Pierre Delord	2021	24
5	983P Phase I dose escalation study in patients (pts) with advanced solid tumours receiving first-in-class BI 765063, a selective signal-regulatory protein α (SIRPα) inhibitor, in combination with ezabenlimab (BI 754091), a programmed cell death protein 1 (PD-1) inhibitor Annals of Oncology ·Nuria Kotecki, Stéphane Champiat, J.P. Delord, Armelle Vinceneux, Christiane Jungels, Aurélien Marabelle, 夏天喜, C D Lokhande, Deokgil Ko, Nicole Clarke, Mhm van der Linden, Nicolas Poirier, Friedrich von Sallet, B. Vasseur, Philippe A. Cassier	2021	10
6	Randomized Phase 2 Trial of a Novel Clonidine Mucoadhesive Buccal Tablet for the Amelioration of Oral Mucositis in Patients Treated With Concomitant Chemoradiation Therapy for Head and Neck Cancer International Journal of Radiation OncologyBiologyPhysics ·J. Giralt, Yungan Tao, Rolf‐Dieter Kortmann, Xavier Zasadny, Jorge Contreras, Philippe Céruse, Fernando Arias de la Vega, Rajesh V. Lalla, Esat Mahmut Özşahin, Gábor Pajkos, Andrew P. Mazar, P Attali, Paolo Bossi, B. Vasseur, Stephen T. Sonis, Michael Henke, René‐Jean Bensadoun	2019	21
7	ATALANTE-1 randomized phase III trial, OSE 2101 versus standard treatment as second- or third-line in HLA-A2 positive advanced non-small cell lung cancer (NSCLC) patients. Journal of Clinical Oncology ·Enriqueta Felip, Giuseppe Giaccone, Rafał Dziadziuszko, Fabrice Denis, Teresa Morán, D. Debieuvre, Manuel Cobo, Domenico Galetta, H R Rajashree, Giampiero Romano, Anne Madroszyk, C. Chouaïd, François‐Régis Ferrand, Werner Hilgers, Federico Cappuzzo, Philippe Masson, Nir Peled, B. Vasseur, Jordi Remón, Benjamin Besse	2019	2
8	Enhanced anti-tumor efficacy of checkpoint inhibitors in combination with the histone deacetylase inhibitor Belinostat in a murine hepatocellular carcinoma model Cancer Immunology Immunotherapy ·Diana Llópiz, Marta Ruiz, Lorea Villanueva, Tamara Iglesias, Leyre Silva, Josune Egea, Juan José Lasarte, 進河崎, Jeremy Glick, B. Vasseur, Nicholas Haltmeyer, Bruno Sangro, Pablo Sarobe	2018	116
9	The HDAC inhibitor belinostat enhances the anti-tumor efficacy of immune checkpoint inhibitors in a murine hepatocellular carcinoma model Journal of Hepatology ·Diana Llópiz, Marta Ruiz, Lorea Villanueva, Tamara Iglesias, Juan José Lasarte, 進河崎, Beau Neep, B. Vasseur, Nicholas Haltmeyer, Bruno Sangro, Pablo Sarobe	2018	1
10	Comparison of the Systemic and Local Pharmacokinetics of Clonidine Mucoadhesive Buccal Tablets with Reference Clonidine Oral Tablets in Healthy Volunteers: An Open-Label Randomised Cross-Over Trial Advances in Therapy ·B. Vasseur, Alain Dufour, MS Wicha, 查柳君, Mackenzie N Breneman, Johanna Håkans, CN Kappagoda	2017	12
11	Safety and efficacy of intra-arterial hepatic chemotherapy with doxorubicin-loaded nanoparticles in hepatocellular carcinoma ESMO Open ·Philippe Merle, Philippe Camus, Armand Abergel, Georges‐Philippe Pageaux, Claude Masliah, J.-P. Bronowicki, Jean Pierre Zarski, Gilles Pelletier, Mohamed Bouattour, Vivien Wei, Étienne Dorval, Joyce A.A., Michael D. VanPelt, M Doffoël, Patrice Couzigou, Julien Taı̈eb, B. Vasseur, P Attali	2017	36
12	P1334 : A multicentre, randomised, open-label study comparing the efficacy and safety of two doses of Doxorubicin TransdrugTM to best standard of care in patients with advanced Hepatocellular Carcinoma (HCC) after sorafenib. The relive study Journal of Hepatology ·Philippe Merle, G Pelletier, François Habersetzer, Giovanni Luca Frassineti, Georges‐Philippe Pageaux, Ivan Borbath, René Gerolami, Gloria Sánchez‐Antolín, J.-P. Bronowicki, Zsolt Horváth, Yann Touchefeu, A Maieron, Henning Wege, Zahraa A.H. Alobaidy, Nashat Gabrail, B. Vasseur, P Attali, Jean‐Frédéric Blanc	2015	3
13	Gene Electrotransfer of Plasmid Antiangiogenic Metargidin Peptide (AMEP) in Disseminated Melanoma: Safety and Efficacy Results of a Phase I First-in-Man Study PubMed ·Iben Spanggaard, Marko Snoj, Andréa Cavalcanti, Céline Bouquet, Gregor Serša, Caroline Robert, Maja Čemažar, Elisabeth Dam, B. Vasseur, P Attali, Lluis M. Mir, Julie Gehl	2013	53
14	Proof of Concept of Gene Therapy Using Plasmid Amep in Disseminated Melanoma: Safety and Efficacy Results of A Phase I First-In-Man Study Annals of Oncology ·Iben Spanggaard, Marko Snoj, Andréa Cavalcanti, Céline Bouquet, Gregor Serša, Caroline Robert, B. Vasseur, P Attali, Lluis M. Mir, Julie Gehl	2012	4
15	Multicenter Phase II Trial of Neoadjuvant Therapy With Trastuzumab, Docetaxel, and Carboplatin for Human Epidermal Growth Factor Receptor-2–Overexpressing Stage II or III Breast Cancer: Results of the GETN(A)-1 Trial Journal of Clinical Oncology ·Bruno Coudert, Rémy Largillier, Laurent Arnould, P. Chollet, Mario Campone, David Coeffic, Frank Priou, Joseph Gligorov, 貞清渡部, V. Trillet-Lenoir, B. Weber, 姜晓杨雲舒, B. Vasseur, Daniel Serin, Moïse Namer	2007	102
16	[Combined transplantation of liver and small intestine in an adult. First case in France. Surgical aspects]. PubMed ·Daniel Azoulay, Éric Savier, D. Castaing, Mónica Andrea Meneses Romero, B. Vasseur, JF Émile, A. L�sche, Didier Samuel, Claude Matuchansky, Bernard Messing, Henri Bismuth	2000	1
17	[Follow-up of liver transplantation]. PubMed ·B. Vasseur, Didier Samuel	1999	2
18	[BIOLOGICAL DETERMINATION OF GASTRIN ON THE RAT]. PubMed ·B. Vasseur, Juan Alejandro Lorenzo Lima	1996	0
19	Steady-state Breathing Pattern Responses to Small Inspiratory Resistive Loads in COPD Patients CHEST Journal ·J.-L. Pourriat, Y. P. Guo, Jean-Philippe Fosse, B. Vasseur, M Cupa	1989	3
20	Diaphragmatic Fatigue and Breathing Pattern during Weaning from Mechanical Ventilation in COPD Patients CHEST Journal ·J.-L. Pourriat, Y. P. Guo, Ju, Xie Cong-xiang, B. Vasseur	1986	56

About B. Vasseur

B. Vasseur is a scholar working on Otorhinolaryngology, Oncology, Immunology, Pharmacy and Hepatology, having authored 34 papers that have together received 887 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (7 papers), Oral health in cancer treatment (4 papers), Phagocytosis and Immune Regulation (4 papers), Lung Cancer Treatments and Mutations (3 papers), Lung Cancer Research Studies (3 papers), Immune cells in cancer (3 papers), Head and Neck Cancer Studies (3 papers) and Respiratory Support and Mechanisms (2 papers). The work is most often cited by research in Oncology (522 citations), Pathology and Forensic Medicine (166 citations), Cancer Research (119 citations), Transplantation (18 citations) and Otorhinolaryngology (27 citations). B. Vasseur has collaborated with scholars based in France, United States and Spain. Frequent co-authors include A.-M. Stoppa, Pierre Quartier, Bruno Hurault de Ligny, Yves Réguerre, J. L. Garnier, C. Antoine, A. Mathieu-Boué, V. Leblond, Didier Bouscary and Nöel Milpied. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, Cancer, Journal of Hepatology and CHEST Journal.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact